Before the development of breast cancer, PD-1+ immune cells in carriers with BRCA1 and BRCA2 germline mutations are preferentially localized near the epithelial tissue, which might be associated with early immune evasion in the malignant epithelial tissue [96]. This evidence concerns the gene BRCA2 and breast carcinoma.